# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-013641
Filing Date
2025-04-14
Accepted
2025-04-14 09:00:27
Documents
18
Period of Report
2025-05-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20046104x2_def14a.htm iXBRL | DEF 14A | 454293
3 | GRAPHIC | ny20046104x2_pc01.jpg | GRAPHIC | 686314
4 | GRAPHIC | ny20046104x2_pc02.jpg | GRAPHIC | 461766
5 | GRAPHIC | ny20046104x2_pvp01.jpg | GRAPHIC | 115439
6 | GRAPHIC | ny20046104x2_pvp02.jpg | GRAPHIC | 114139
7 | GRAPHIC | ny20046104x2_pvp03.jpg | GRAPHIC | 90782
| Complete submission text file | 0001140361-25-013641.txt |  | 4586796

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | nrxs-20250529.xsd | EX-101.SCH | 2121
21 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20046104x2_def14a_htm.xml | XML | 84874

Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41775 | Film No.: 25834321
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)